Table 1 Results of blood culture testing of IBD and non-IBD patients (January 2017–December 2019)
Number of blood cultures performed in IBD patients n | Positive results n/% | Microorganisms cultured | Number | %In relation to all samples taken | %In relation to positive results |
|---|---|---|---|---|---|
Results of blood culture testing of IBD patients | |||||
24 | 10/41.7% | Staphylococcus epidermidis MRCNS | 4 | 16.7% | 40.0% |
Staphylococcus aureus | 1 | 4.2% | 10.0% | ||
Escherichia coli | 3 | 12.5% | 30.0% | ||
Cutibacterium acnes | 1 | 4.2% | 10.0% | ||
Micrococcus luteus | 1 | 4.2% | 10.0% | ||
Results of blood culture testing of non-IBD patients | |||||
844 | 77/9.1% | Staphylococcus epidermidis MRCNS | 33 | 3.9% | 42.8% |
Staphylococcus epidermidis | 9 | 1.1% | 11.7% | ||
Staphylococcus aureus MRSA | 2 | 0.24% | 2.6% | ||
Staphylococcus aureus | 2 | 0.24% | 2.6% | ||
Enterococcus faecium | 4 | 0.47% | 5.2% | ||
Enterococcus faecalis | 2 | 0.24% | 2.6% | ||
Escherichia coli | 5 | 0.6% | 6.5% | ||
Escherichia coli ESBL | 2 | 0.24% | 2.6% | ||
Enterobacter cloaceae | 4 | 0.47% | 5.2% | ||
Enterobacter aerogenes | 3 | 0.35% | 3.9% | ||
Acinetobacter baumanii | 2 | 0.24% | 2.6% | ||
Citrobacter freundii | 2 | 0.24% | 2.6% | ||
Streptococcus anginosus | 2 | 0.24% | 2.6% | ||
Pseudomonas aeruginosa | 1 | 0.12% | 1.3% | ||
Cutibacterium acnes | 3 | 0.35% | 3.9% | ||
Candida albicans | 1 | 0.12% | 1.3% | ||